ALD1613, a Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven Pharmacology.
Feldhaus, Andrew L
ALD1613, a Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven Pharmacology. [electronic resource] - Endocrinology 01 2017 - 1-8 p. digital
Publication Type: Journal Article
1945-7170
10.1210/en.2016-1455 doi
Adrenal Hyperplasia, Congenital--drug therapy
Adrenocorticotropic Hormone--antagonists & inhibitors
Animals
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Humanized
CHO Cells
Corticosterone--blood
Cricetinae
Cricetulus
Drug Evaluation, Preclinical
Humans
Hydrocortisone--blood
Macaca fascicularis
Male
Pituitary ACTH Hypersecretion--drug therapy
Rabbits
Rats
Rats, Inbred Lew
Receptor, Melanocortin, Type 2--metabolism
Stress, Psychological--blood
ALD1613, a Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven Pharmacology. [electronic resource] - Endocrinology 01 2017 - 1-8 p. digital
Publication Type: Journal Article
1945-7170
10.1210/en.2016-1455 doi
Adrenal Hyperplasia, Congenital--drug therapy
Adrenocorticotropic Hormone--antagonists & inhibitors
Animals
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Humanized
CHO Cells
Corticosterone--blood
Cricetinae
Cricetulus
Drug Evaluation, Preclinical
Humans
Hydrocortisone--blood
Macaca fascicularis
Male
Pituitary ACTH Hypersecretion--drug therapy
Rabbits
Rats
Rats, Inbred Lew
Receptor, Melanocortin, Type 2--metabolism
Stress, Psychological--blood